About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,344 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,344 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3001-3020 of 3,344 trials

CompletedTemozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to MelanomaThis phase II trial is studying how well giving temozolomide together with thalidomide works in treating patients with brain metastases secondary to melanoma.NCT00072163·Chicago, Illinois TerminatedStudy of Temzolomide and Gleevec in Advanced MelanomaThis study has been designed to evaluate the side effects of Gleevec when given in combination with Temzolomide; and to learn more about how these drugs work in the body and…NCT00667953·Philadelphia, Pennsylvania UnknownRecombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant MelanomaThis study is the first to explore the efficacy and safety of recombinant human adenovirus type 5 injection combined with PD-1 monoclonal antibody and nab-paclitaxel in the…NCT05664139 WithdrawnQuantifying Systemic Immunosuppression to Personalize Cancer TherapyIt is nowadays well established that the immune system can profoundly influence disease outcome in cancer patients.NCT04941365

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

CompletedLymph Node Identification in Skin Malignancy Using ICG Transcutaneously StudyA diagnostic sensitivity study comparing intradermal indocyanine green (ICG) and near infrared fluorescence imaging (NIRFI) with intradermal technetium 99m and traditional…NCT03545334·Bern, Canton of Bern

WithdrawnSBRT as a Vaccination for Metastatic MelanomaImmunotherapy with PD-1 blockade is a first-line treatment for patients with advanced melanoma, but unfortunately most patients progress on this therapy.NCT04042506·Baltimore, Maryland and 1 other

CompletedRetrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics DataThis study is a retrospective one, exploring the hypothesis that a person's genotypic makeup may be associated with a clinical response or toxic effect to a drug.NCT00341939·Bethesda, Maryland

CompletedRegistry Study for Talimogene LaherparepvecA Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical TrialsNCT02173171·Mobile, Alabama and 58 others

UnknownIdentifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary MelanomaRATIONALE: Identifying gene mutations and other risk factors in patients with melanoma and in families with a history of hereditary melanoma may help doctors identify persons at…NCT00450593·Leeds, England

CompletedBCX-1777 in Treating Patients With Refractory CancerRATIONALE: BCX-1777 may stop the growth of cancer cells by blocking the enzymes necessary for their growth.NCT00073944·Cleveland, Ohio

CompletedPhase II, 2nd Line Melanoma - RAND MonotherapyThe main purpose of this study is to estimate the proportion of patients with a type of skin cancer called melanoma who are progression free, (that is, the cancer has not gotten…NCT00612664·Los Angeles, California and 31 others

CompletedRiluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryRATIONALE: Riluzole may stop or slow the growth of tumor cells and may be an effective treatment for melanoma.NCT00866840·New Brunswick, New Jersey

CompletedHigh-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)The purpose of this study is to establish the pharmacokinetics of PEG-Intron, administered at a dose of 6 μg/kg/week for 8 weeks (induction treatment), followed by a dose of 3…NCT00457418

Active not recruitingMinimal SN Tumor BurdenThe purpose of this registry is to collect data in order to discover whether melanoma patients with minimal SN tumor burden should undergo a complete lymph node dissection (CLND)…NCT01942603·Leuven and 21 others

TerminatedPhase II FANG™ in Advanced MelanomaPreliminary studies with a variety of vaccines suggest target accessibility (potential immunogenicity) in a variety of solid tumors to immune directed approaches.NCT01453361·Dallas, Texas

TerminatedQUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic MelanomaThis is a Phase Ib/II, open-label, multi-center, competitive enrollment and dose-escalation study of ALT-801 combined with cisplatin.NCT01029873·Los Angeles, California and 7 others

CompletedCan We Miss Pigmented Lesions in Psoriasis Patients?In psoriasis patients, thick psoriatic plaques can obscure these lesions, and clinicians rely heavily on visual inspection to recognize suspicious or atypical pigmented lesions.NCT01053819·Birmingham, Alabama

TerminatedPositron Emission Tomography/Magnetic Resonance Imaging in PatientsThis clinical trial studies positron emission tomography (PET)/magnetic resonance imaging (MRI) in patients undergoing PET/computed tomography (CT).NCT01557881·Cleveland, Ohio

CompletedPhase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic MelanomaThe purpose of this study is to find out how effective an investigational drug named ZK-Epo is against melanoma.NCT00598507·Tampa, Florida

CompletedUsing High Resolution Function Imaging To Detect Melanoma and Dysplastic NeviA novel infrared imaging tool to aid in the clinical detection of atypical pigmented lesions and melanoma is developed.NCT01118832·Baltimore, Maryland

PreviousPage 151 of 168Next